Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ASAP CC
- Development stage
- Unknown
- Lead developer
- Anglo-French Drugs & Industries
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
ASAP CC is an oral, small-molecule fixed-dose combination tablet developed by Anglo-French Drugs & Industries for the symptomatic relief of the common cold, cough, flu, and associated allergic symptoms. It contains three active pharmaceutical ingredients: chlorpheniramine maleate (an antihistamine), dextromethorphan hydrobromide (a cough suppressant), and phenylephrine hydrochloride (a nasal decongestant). Chlorpheniramine acts as an antagonist at the histamine H1 receptor to alleviate sneezing, runny nose, and watery eyes. Dextromethorphan suppresses the cough reflex by acting as an agonist at the sigma-1 receptor and an antagonist at NMDA receptors in the central nervous system. Phenylephrine acts as an agonist at alpha-1 adrenergic receptors, causing vasoconstriction in the nasal mucosa to relieve nasal congestion.
- Brand names
- ASAP CC
- Other names
- ASAP CC TabletAsap CC
02
Targets
ADRA1A (α1A)GRIN2A (NMDA receptor subunit 2A)HRH1 (Histamine H1 Receptor)SIGMAR1 (Sigma non-opioid intracellular receptor 1)
Beyond the preview
Go deeper on ASAP CC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ASAP CC.